Articles tagged with: Daratumumab

News, Opinion»

[ by | Jul 23, 2014 2:56 pm | 14 Comments ]
The Myeloma Quiz – July 2014

It’s July, and we have had some time to digest the findings from the American Society of Clinical Oncology (ASCO) annual meeting held in Chicago May 30 through June 3.

Quite a few presentations caught one’s eye.

We finally saw the results of the much awaited PANORAMA-1 study in­ves­ti­gating the efficacy and safety of panobinostat (LBH589) plus Velcade and dexa­meth­a­sone compared to Velcade and dexamethasone alone.

Exciting data on the CD38 antibodies daratumumab and SAR650984 continued to emerge at ASCO.

Another study looked at …

Read the full story »


[ by | Jun 4, 2014 11:25 am | 2 Comments ]
ASCO 2014 Multiple Myeloma Update – Day Four: Oral Presentations

This year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago came to an end yesterday.

The fourth day of the meeting, which was Monday, was the busiest day in regard to myeloma-related re­search. It started with an oral presentation session that included seven talks about im­por­tant new myeloma-related re­search. A poster session in the afternoon included several posters about myeloma-related re­search.

This article summarizes the most important findings from Monday’s oral pre­sen­ta­tion session. A later article will cover the findings from the after­noon poster session.

The …

Read the full story »


[ by | May 31, 2014 9:17 pm | 3 Comments ]
ASCO 2014 Multiple Myeloma Update – Day One

This year’s American Society of Clinical Oncology (ASCO) annual meeting began yester­day morning in Chicago and will run through Tuesday.

Myeloma-related presentations were made during two sessions yes­ter­day.

One session was designed to better educate physicians about per­son­al­ized therapy for elderly patients with lymphoid malignancies. During that session, Dr. Tanya Marya Wildes from the Washington University School of Medicine in St. Louis talked about how to navigate treatment options for older multiple myeloma patients.

The key myeloma-related research presented yesterday was made public during a poster session in the afternoon …

Read the full story »


[ by | May 15, 2014 1:01 pm | 5 Comments ]
Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2014)

The American Society of Clinical Oncology will hold its 50th annual meet­ing May 30 through June 3 in Chicago.

Similar to previous years, more than 25,000 physicians and researchers from all over the world are expected to attend the five-day meeting to dis­cuss the current research in cancer treatment and care.

During the meeting, there will be presentations about all areas of cancer, in­clud­ing many focused specifically on multiple myeloma. The ASCO website currently lists information about more than 60 myeloma-related studies (included under either the “multiple myeloma” or “

Read the full story »


[ by | Mar 1, 2014 5:56 pm | 2 Comments ]
The Top Myeloma Research Of 2013

The year 2013 is likely to be remembered as a very good year when it comes to research related to multiple myeloma.

Previous years have witnessed research shedding new light on existing my­e­lo­ma therapies, as well as additional research about potential new therapies.

But, in the past, most of the important new therapies that were being researched were from existing classes of therapy, making them less likely to offer dramatic im­prove­ments in the treat­ment of the disease.

In 2013, not only was there more research about existing therapies, and more …

Read the full story »